Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles

Stroke

Volumn 28, Issue 4, 1997, Pages 837-843

  Sobey, Christopher G ^a   Faraci, Frank M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

cerebral arteries; mice; nitric oxide; vasodilation

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; 6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; ACETYLCHOLINE; ADENOSINE; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; QUINOXALINE DERIVATIVE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTICLE; BRAIN ARTERY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VASODILATATION;

EID: 0030971174     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.4.837     Document Type: Article

References (40)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43: 109-142.
2. Faraci FM, Brian JE. Nitric oxide and regulation of the cerebral circulation. Stroke. 1994;25:692-703.
3. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic cGMP. Circulation. 1995;92: 3337-3349.
4. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
5. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 265:C799-C822.
6. + channels in relaxations of hypercholesterolemic rabbit carotid artery to NO. Am J Physiol. 1995;269:H805-H811.
7. Sobey CG, Faraci FM. Effect of nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter. Am J Physiol. 1997;272:H256-H262.
8. Marshall JJ, Wei EP, Kontos HA. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol. 1988;255:H847-H854.
9. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G. Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther. 1990;254:872-876.
10. Marczin N, Ryan US, Catravas JD. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther. 1992;263:170-179.
11. Kontos HA, Wei EP. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke. 1993:24:427-434.
12. Mulsch A, Busse R, Liebau S, Forstermann U. LY-83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther. 1988;247:283-288.
13. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol. 1993;45:367-374.
14. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol. 1995;48:184-188.
15. Fedele E, Jin Y, Varnier G, Raiteri M. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br J Pharmacol. 1996; 119:590-594.
16. Brunner F, Schmidt K, Nielsen EB, Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther. 1996;277:48-53.
17. Brunner F, Stessel H, Kukovetz WR. Novel guanylyl cyclase inhibitor, ODO reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett. 1995;376:262-266.
18. Schrammel A, Behrends S, Schmidt K, Koesling D, Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol. 1996;50:1-5.
19. Moro MA, Russell RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci. 1996;93:1480-1485.
20. Cellek S, Kasakov L, Moncada S. Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br J Pharmacol. 1996;118:137-140.
21. Rosenblum WI, Nishimura H, Nelson GH. Endothelium-dependent L-arg- and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. Am J Physiol. 1990;259:H1396-H1401.
22. Irikura K, Huang PL, Ma J, Lee WS, Dalkara T, Fishman MC, Dawson TM, Snyder SH, Moskowitz MA. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci U S A. 1995;92:6823-6827.
23. Ma J, Ayata C, Huang PL, Fishman MC, Moskowitz MA. Regional cerebral blood flow response to vibrissal stimulation in mice lacking type I NOS gene expression. Am J Physiol. 1996;270:H1085-H1090.
24. Meng W, Ma J, Ayata C, Hara H, Huang PL, Fishman MC, Moskowitz MA. ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol. 1996;271:H1145-H1150.
25. Faraci FM. Regulation of the cerebral circulation by endothelium. Pharmacol Ther. 1992;56:1-22.
26. Rosenblum WI. Endothelial-dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke. 1986;17:494-497.
27. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol. 1991; 261:H1038-H1042.
28. Wei EP, Kukreja R, Kontos HA. Effects of inhibition of nitric oxide synthesis on cerebral vasodilation and endothelium-derived relaxing factor from acetylcholine. Stroke. 1992;23:1623-1629.
29. Faraci FM, Breese KR, Heistad DD. Nitric oxide contributes to dilatation of cerebral arterioles during seizures. Am J Physiol. 1993; 265:H2209-H2212.
30. Colonna DM, Meng W, Deal DD, Busija DW. Nitric oxide promotes arteriolar dilation during cortical spreading depression in rabbits. Stroke. 1994;25:2463-2470.
31. Onoue H, Kaito N, Tomii S, Tokudome S, Nakajima M, Abe T. Human basilar and middle cerebral arteries exhibit endothelium-dependent responses to peptides. Am J Physiol. 1994;267: H880-H886.
32. Petersson J, Zygmunt PM, Brandt L, Hogestatt ED. Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br J Pharmacol. 1995;115:889-894.
33. Edvinsson L, Fredholm BB. Characterization of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol. 1983; 80:631-637.
34. Ngai AC, Winn HR. Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circ Res. 1995;77:832-840.
35. 2 purine receptors in brain circulation. Eur J Pharmacol. 1987;144:343-352.
36. Koenig HM, Pelligrino DA, Albrecht RF. Halothane vasodilation and nitric oxide in rat pial vessels. J Neurosurg Anesthesiol. 1993;5: 264-271.
37. Reidel MW, Anneser F, Haberl RL. Different mechanisms of L-arginine induced dilation of brain arterioles in normotensive and hype
38. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab. 1996;16:981-987.
39. Rosenblum WI, Zweifach BW. Cerebral microcirculation in the mouse brain. Arch Neurol. 1963;9:414-423.
40. Dalkara T, Irikura K, Huang Z, Panahian N, Moskowitz M. Cerebrovascular responses under controlled and monitored physiological conditions in the anesthetized mouse. J Cereb Blood Flow Metab. 1995;15:631-638.